Sort   by:  
 Page size 
UnknownTransformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Not available
S-EPMC12481261 | biostudies-literature
UnknownA Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.
Not available
S-EPMC7056559 | biostudies-literature
Sort   by:  
 Page size